Pregnancy and perinatal outcomes following exposure to antineoplastic agents around pregnancy within the US FDA Adverse Event Reporting System

Trastuzumab administration during pregnancy: un update

(2021) Angeliki Andrikopoulou et al.   BMC CANCER

Association of Chemotherapy Timing in Pregnancy With Congenital Malformation

(2021) Mathilde van Gerwen et al.   JAMA Network Open

Association between Thiopurines Use and Pregnancy Outcomes in Female Patients with Inflammatory Bowel Disease: A Meta-analysis

(2020) Yang Zhang et al.   CURRENT PHARMACEUTICAL DESIGN

Outcomes of children exposed to chemotherapy in utero for breast cancer.

(2017) J. K. Litton et al.   JOURNAL OF CLINICAL ONCOLOGY

Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2013) F. A. Peccatori et al.   ANNALS OF ONCOLOGY

Maternal and fetal outcomes of taxane chemotherapy in breast and ovarian cancer during pregnancy: case series and review of the literature

(2012) E. Cardonick et al.   ANNALS OF ONCOLOGY

Treatment of breast cancer during pregnancy: an observational study

(2012) Sibylle Loibl et al.   LANCET ONCOLOGY

Perinatal Outcomes of a Pregnancy Complicated by Cancer, Including Neonatal Follow-Up After in Utero Exposure to Chemotherapy

(2010) Elyce Cardonick et al.   AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS

Substantial Variation in Transplacental Transfer of Chemotherapeutic Agents in a Mouse Model

(2010) Kristel Van Calsteren et al.   Reproductive Sciences

Treatment of the pregnant mother with cancer: A systematic review on the use of cytotoxic, endocrine, targeted agents and immunotherapy during pregnancy. Part II: Hematological tumors

(2009) Hatem A. Azim et al.   CANCER TREATMENT REVIEWS

Treatment of the pregnant mother with cancer: A systematic review on the use of cytotoxic, endocrine, targeted agents and immunotherapy during pregnancy. Part I: Solid tumors

(2009) Hatem A. Azim et al.   CANCER TREATMENT REVIEWS

Cancer During Pregnancy: An Analysis of 215 Patients Emphasizing the Obstetrical and the Neonatal Outcomes

(2009) Kristel Van Calsteren et al.   JOURNAL OF CLINICAL ONCOLOGY